Walleye Capital LLC Sanofi Call Options Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$48.54 - $58.53 $2.61 Million - $3.14 Million	53,700 Added 1032.69%	58,900 $3.4 Million
Q2 2024 Aug 14, 2024	BUY	$45.39 - $50.36 $236,028 - $261,872	5,200 New	5,200 $252,000
Q4 2023 Feb 14, 2024	SELL	$43.13 - $54.79 $276,032 - $350,656	-6,400 Reduced 10.46%	54,800 $2.73 Million
Q3 2023 Nov 14, 2023	BUY	$50.95 - $55.2 $2.85 Million - $3.09 Million	55,900 Added 1054.72%	61,200 $3.28 Million
Q2 2023 Aug 14, 2023	BUY	$50.45 - $57.18 $30,270 - $34,308	600 Added 12.77%	5,300 $285,000
Q1 2023 May 15, 2023	BUY	$45.86 - $54.45 $215,542 - $255,915	4,700 New	4,700 $255,000

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $121B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.